Compare PGEN & AEYE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PGEN | AEYE |
|---|---|---|
| Founded | 1998 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 91.0M |
| IPO Year | 2013 | 2011 |
| Metric | PGEN | AEYE |
|---|---|---|
| Price | $4.36 | $7.75 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 4 |
| Target Price | $8.33 | ★ $14.63 |
| AVG Volume (30 Days) | ★ 3.3M | 120.1K |
| Earning Date | 05-13-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 30.56 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $230,981,000.00 | $40,311,000.00 |
| Revenue This Year | $1,115.92 | $11.12 |
| Revenue Next Year | $81.04 | $11.45 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 14.52 |
| 52 Week Low | $1.28 | $5.31 |
| 52 Week High | $5.47 | $16.39 |
| Indicator | PGEN | AEYE |
|---|---|---|
| Relative Strength Index (RSI) | 55.30 | 58.81 |
| Support Level | $3.96 | $6.09 |
| Resistance Level | $4.40 | $8.20 |
| Average True Range (ATR) | 0.27 | 0.51 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 46.74 | 85.75 |
Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.
AudioEye Inc is a software solution provider delivering immediate ADA and WCAG accessibility compliance at scale. Through patented technology, subject matter expertise and proprietary processes, it is eradicating all barriers to digital accessibility, helping creators get accessible and supporting them with ongoing advisory and automated upkeep. It helps everyone identify and resolve issues of accessibility and enhance user experiences, automating digital accessibility for the widest audiences. It generates revenue through the sale of subscriptions for software-as-a-service (SaaS). accessibility solutions.